The WHO rules stipulate that manufacturers should establish and adhere to detailed routine maintenance schedules according to devices specs and use designs. Manufacturers trying to put into action these procedures have to give robust validation information to reveal their equivalence to pharmacopoeial procedures. As these new technologies arise, the waiting for link from Forum Profiles (11)